BXTAccelyon is a leading partner to hospitals and clinics worldwide in providing low dose rate (LDR) brachytherapy and related solutions to treat prostate cancer.
Founded in 2012, BXTAccelyon takes pride in its collaborative, partnership approach with radiotherapy centres across the world.
The Iodine-125 seeds supplied by BXTAccelyon have been widely used for over 25 years to treat prostate cancer patients successfully. Supplying the correct product prescription is time-critical in brachytherapy and through its webBXT e-commerce platform, BXTAccelyon ensures an efficient supply chain system that is guaranteed to deliver to the highest standards of quality and reliability.
BXTAccelyon’s exclusive 4D Brachytherapy™, a unique one-stage implant technique that can be completed in under an hour, developed in collaboration with urology specialists, is proven to deliver improved time efficiency, patient experience and clinical outcomes.